Feature Image

Medical Marijuana, Inc. Subsidiary Kannaway® Hosts Exclusive Premium Humulus Oil Training Webinar on July 17

SAN DIEGO, July 16, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® will host an exclusive premium humulus training webinar to answer questions about its new Premium Humulus Oil product on July 17, 2018.

The primary ingredient in Premium Humulus Oil is ImmunAg™, a Kriya brand Humulus extract and the first cannabidiol (CBD) oil supplement not derived from the cannabis plant. Dr. Stuart Titus, CEO of Medical Marijuana, Inc., ImmunAg™ creator and partner Dr. Bomi Joseph, and Blake Schroeder, CEO of Kannaway® will answer viewer questions and discuss the history of the product.

“We’re very proud to be the distributors of the first, and only, non-cannabis derived CBD product on the market and want to help our customers understand what the product is and its health and wellness benefits,” Titus said. “There has been a tremendous amount of public interest surrounding Premium Humulus Oil and we believe that this training webinar is the best way to help people understand what the product is and why they should be taking it as a daily supplement.”

“I am very excited to present with Stuart Titus and Blake Schroeder to educate people on Premium Humulus Oil,” said Director of Peak Health Dr. Bomi Joseph. “It is encouraging to have an opportunity to share more in-depth information about the development of the new product.”

During the webinar, Dr. Joseph will be sharing the exciting story of the background behind Kriya brand Humulus, the journey he took to discover it and the supporting science around the world’s first non-cannabis CBD source. This is an unprecedented opportunity to hear from Dr. Joseph himself and to learn first-hand the amazing story of Kriya brand Humulus that took a decade to develop.

“We are thrilled to see the excitement people have for our new product, Kannaway Premium Humulus Oil,” said Kannaway® CEO Schroeder. “This product offers a welcome alternative for people who want to try CBD but can’t due to their job or government restrictions. Now, they have a chance to reap the benefits of CBD without cannabis.”

The exclusive product background and training webinar will take place on Tuesday, July 17, at 6:00PM PST. To sign up, please visit the Kannaway® website.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.

About Kannaway®

Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Peak Health

Peak Health Center is a 501(c)(3), Not-For-Profit Corporation, based out of Los Gatos, CA. Its charter is to improve human health, with the least use of pharmaceutical drugs. Its researchers from around the globe are volunteering efforts to enhance our knowledge of endogenous health and phytotherapy.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSURE

Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil. In addition, the company now produces legal Humulus-based products, which are considered GRAS and a “food ingredient”.

CONTACT:

Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]

www.cmwmedia.com